Literature DB >> 8555791

The future of breast and ovarian cancer clinics.

H Campbell, J MacKay, M Porteous.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 8555791      PMCID： PMC2551490          DOI： 10.1136/bmj.311.7020.1584

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Is screening for ovarian cancer worthwhile?

Authors:  J Philip
Journal:  J Med Screen       Date:  1994-10       Impact factor: 2.136

2.  A question that will not go away: at what age should mammographic screening begin?

Authors:  A P Forrest; F E Alexander
Journal:  J Natl Cancer Inst       Date:  1995-08-16       Impact factor: 13.506

3.  Assessment and counseling for women with a family history of breast cancer. A guide for clinicians.

Authors:  K F Hoskins; J E Stopfer; K A Calzone; S D Merajver; T R Rebbeck; J E Garber; B L Weber
Journal:  JAMA       Date:  1995-02-15       Impact factor: 56.272

Review 4.  Familial breast cancer.

Authors:  D G Evans; I S Fentiman; K McPherson; D Asbury; B A Ponder; A Howell
Journal:  BMJ       Date:  1994-01-15

5.  Susceptibility genes for breast cancer.

Authors:  B L Weber
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

6.  Genetic counseling for families with inherited susceptibility to breast and ovarian cancer.

Authors:  B B Biesecker; M Boehnke; K Calzone; D S Markel; J E Garber; F S Collins; B L Weber
Journal:  JAMA       Date:  1993-04-21       Impact factor: 56.272

Review 7.  Inherited susceptibility to breast cancer.

Authors:  D Easton; D Ford; J Peto
Journal:  Cancer Surv       Date:  1993

Review 8.  Setting up and running a familial cancer clinic.

Authors:  B A Ponder
Journal:  Br Med Bull       Date:  1994-07       Impact factor: 4.291

9.  Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; D T Bishop; S A Narod; D E Goldgar
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321
  9 in total
  7 in total

1.  A model protocol evaluating the introduction of genetic assessment for women with a family history of breast cancer.

Authors:  J Gray; K Brain; P Norman; C Anglim; L France; G Barton; L Branston; E Parsons; A Clarke; J Sampson; E Roberts; R Newcombe; D Cohen; C Rogers; R Mansel; P Harper
Journal:  J Med Genet       Date:  2000-03       Impact factor: 6.318

2.  Specialist breast and ovarian cancer clinics should be staffed by oncologist nurses.

Authors:  B A Stoll
Journal:  BMJ       Date:  1996-04-06

3.  A randomized trial of specialist genetic assessment: psychological impact on women at different levels of familial breast cancer risk.

Authors:  K Brain; P Norman; J Gray; C Rogers; R Mansel; P Harper
Journal:  Br J Cancer       Date:  2002-01-21       Impact factor: 7.640

4.  Estimating the survival benefits gained from providing national cancer genetic services to women with a family history of breast cancer.

Authors:  G L Griffith; R T Edwards; J Gray; C Wilkinson; J Turner; B France; P Bennett
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

5.  Referrals of women with a family history of breast cancer from primary care to cancer genetics services in South East Scotland.

Authors:  H Campbell; S Holloway; R Cetnarskyj; E Anderson; R Rush; A Fry; D Gorman; M Steel; M Porteous
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

6.  Patient satisfaction with two different models of cancer genetic services in south-east Scotland.

Authors:  S Holloway; M Porteous; R Cetnarskyj; E Anderson; R Rush; A Fry; D Gorman; M Steel; H Campbell
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

7.  A randomised controlled trial of breast cancer genetics services in South East Scotland: psychological impact.

Authors:  A Fry; A Cull; S Appleton; R Rush; S Holloway; D Gorman; R Cetnarskyj; R Thomas; J Campbell; E Anderson; M Steel; M Porteous; H Campbell
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.